INDIANAPOLIS Eli Lilly and Transition Therapeutics have agreed on a deal worth up to $130 million, according to the Associated Press. Eli Lilly would acquire worldwide rights to develop and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results